Drawing on more than 20 years of comprehensive clinical and surgical practice, this board-certified urologist and urologic surgeon (M.D.), a Diplomate of the American Board of Urology, has experience in general urology, urologic oncology, robotic surgery, bladder dysfunction, prosthetic urology, and female pelvic reconstructive procedures. Education includes completion of medical school and postgraduate urology residency training at nationally recognized academic institutions, and professional credentials include active medical licensure and board certification in urology, supporting standards-based opinions grounded in clinical practice, surgical expertise, research leadership, and professional oversight experience. The expert has provided litigation consultation, deposition testimony, and trial testimony for 5+ years in cases involving urologic diagnosis, surgical decision-making, oncologic management, and standards of care, including extensive medical record review and preparation of detailed expert analyses.

Specialized training includes robotic (da Vinci) laparoscopic prostatectomy and robotic kidney surgery. Leadership roles include service as Chair of a Urologic Oncology Tumor Board and President of a regional urological society, reflecting active engagement in multidisciplinary cancer review, treatment planning, and professional governance.

The expert has served as Principal Investigator in a randomized, double-blinded, placebo-controlled Phase II clinical trial evaluating therapies for hormone-refractory prostate cancer and has conducted research on detrusor overactivity, demonstrating sustained involvement in clinical research and evidence-based practice.